“PSMA-PET enables us to study the potential benefit of treating all sites of disease with surgery or radiation as opposed to chemotherapy or other medicines. The research potential is enormous.”
-BC Cancer Radiation Oncologist Dr. Abraham Alexander.
BC Cancer - Victoria
BC Cancer – Victoria is one of six regional cancer centres.
Patients have access to:
- world-class comprehensive cancer care and treatment close to home
- vital supportive care services ranging from genetic or nutrition counselling to spiritual guidance
World-Class Deeley Research Centre
Located in Victoria, the Deeley Research Centre (DRC) is one of the first sites in the world to pioneer an immunotherapy research program that uses genomic approaches to generate more precise and potent immune responses against cancer.
Immunotherapy Clinical Trials
Deeley Research Centre Director Dr. Brad Nelson and his team are joining forces with experts at BC Cancer’s Genome Sciences Centre in Vancouver to deliver truly personalized immunotherapy to patients in B.C.
Adoptive T Cell Therapy (ACT) is one of the most promising forms of immunotherapy. ACT clinical trials have the potential to save the lives of British Columbians facing all types of cancer.
Bringing New Hope to Prostate Cancer Patients
Donors are critical to a game-changing expansion of a prostate cancer trial. The Prostate-Specific Membrane Antigen (PSMA) clinical trial will harness PET technology and transform prostate cancer treatment at BC Cancer – Victoria and beyond.
This trial extends from the PSMA program already established in Vancouver and will support earlier, more accurate detection of disease spread in prostate cancer patients utilizing PSMA-PET imaging, which will help inform treatment.
PSMA-PET also helps guide treatment for patients whose cancer has not spread, has returned or has spread to only a limited number of sites. The impact on patients is significant, now and into the future.
With your help, we can transform prostate cancer detection and treatment throughout the province.